4505 EMPEROR BOULEVARD, DURHAM, NC
Transaction Valued at $250 Million to Drive ORLADEYO Sales
Changes in Board, Management or Compensation
Financial Results, Reg. FD
Changes in Board, Management or Compensation, Reg. FD
Appoints Babar Ghias Chief Financial Officer and Head of Corporate Development
News, Reorganization Plan
Announces Sale of European ORLADEYO® (berotralstat) Business to Neopharmed Gentili for up to $264 Million
Other Events
Q2
Q1
FY 2023
Q3
Prospectus Filed Pursuant to Rule 425
Registration Statement for Securities to be Offered to Employees
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Initial Statement of Beneficial Ownership
Submission Upload
Correspondence
SEC Staff Correspondence